| 臺大學術典藏 |
2021-10-25T02:57:50Z |
Detection of serum gamma interferon in nasopharyngeal carcinoma patients using reversed passive hemagglutination method
|
Tsai S.-T; |JENG-YUH KO; |Lynn T.-C; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:50Z |
Serum B-protein in patients with nasopharyngeal carcinoma
|
JENG-YUH KO; |Tsai S.T; |Hsu M.M. |
| 臺大學術典藏 |
2021-10-25T02:57:49Z |
Radiation-Induced Malignant Fibrous Histiocytoma in Patients With Nasopharyngeal Carcinoma
|
JENG-YUH KO; |Chen C.-L; |Tak Lui L; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:48Z |
Undifferentiated carcinoma of the major salivary glands
|
Sheen T.-S; |Tsai C.-C; |JENG-YUH KO; |Chang Y.-L; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:47Z |
Increased mutagen sensitivity in patients with head and neck cancer is less pronounced in patients with nasopharyngeal carcinoma
|
JENG-YUH KO; |Lui L.T; |Sheen T.-S; |Lou P.-J; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:46Z |
Nasopharyngeal swab and pcr for the screening of nasopharyngeal carcinoma in the endemic area: A good supplement to the serologic screening
|
Sheen T.-S; |JENG-YUH KO; |Chang Y.-L; |Chang Y.-S; |Huang Y.-T; |Chang Y; |Tsai C.-H; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:46Z |
Familial clustering of nasopharyngeal carcinoma.
|
JENG-YUH KO; |Sheen T.S; |Hsu M.M; |Lui L.T. |
| 臺大學術典藏 |
2021-10-25T02:57:46Z |
Loss of heterozygosity on chromosomes 3 and 11 in a radiation-induced malignant fibrous histiocytoma - Case report
|
JENG-YUH KO; |Jou Y.-S; |Chen P.-J; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:45Z |
Nasopharyngeal angiofibroma: A reappraisal of clinical features and treatment at National Taiwan University Hospital
|
Yang P.-W; |Sheen T.-S; |JENG-YUH KO; |Liu H.-M; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:44Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; |Sheen T.S; |JENG-YUH KO; |Hsu M.M; |Wang C.C; |Ting L.L. |
| 臺大學術典藏 |
2021-10-25T02:57:44Z |
Erratum: Nasopharyngeal angiofibroma: A reappraisal of clinical features and treatment at National Taiwan University Hospital (Journal of the Formosan Medical Association (1998) 97 (845-9))
|
Yang P.W; |Sheen T.S; |JENG-YUH KO; |Liu H.M; |Hsu M.M. |
| 臺大學術典藏 |
2021-10-25T02:57:44Z |
Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma
|
Sheen T.-S; |Huang Y.-T; |Chang Y.-L; |JENG-YUH KO; |Wu C.-S; |Yu Y.-C; |Tsai C.-H; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:43Z |
Herpes tester oticus treated with acyclovir and prednisolone: Clinical manifestations and analysis of prognostic factors
|
JENG-YUH KO; |Sheen T.-S; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:43Z |
Usefulness of the C1 transverse process as a reference guide in the dissection of the upper lateral neck
|
Sheen T.-S; |Yen K.L; |JENG-YUH KO; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:43Z |
Dysphagia after radiotherapy: Endoscopic examination of swallowing in patients with nasopharyngeal carcinoma
|
Wu C.-H; |JENG-YUH KO; |Hsiao T.-Y; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:41Z |
Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT, p16INK4a, and p19ARF genes in nasopharyngeal carcinoma
|
JENG-YUH KO; |Lee T.-C; |Hsiao C.-F; |Lin G.-L; |Yen S.-H; |Chen K.Y; |Hsiung C.A; |Chen P.-J; |Hsu M.-M; |Jou Y.-S. |
| 臺大學術典藏 |
2021-10-25T02:57:41Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; |Ting L.-L; |JENG-YUH KO; |Hsu M.-M; |Sheen T.-S; |Lou P.-J; |Wang C.-C; |Chung N.-N; |Lui L.T. |
| 臺大學術典藏 |
2021-10-25T02:57:41Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L; |Hsu C.-H; |Lin J.-K; |Hsu M.-M; |Ho Y.-F; |She T.-S; |JENG-YUH KO; |Lin J.-T; |Lin B.-R; |Wu M.-S; |Yu H.-S; |Jee S.-H; |Chen G.-S; |Chen T.-M; |Chen C.-A; |Lai M.-K; |Pu Y.-S; |Pan M.-H; |Wang Y.-J; |Tsai C.-C; |Hsieh C.-Y. |
| 臺大學術典藏 |
2021-10-25T02:57:40Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; |Lin C.-Y; |Ting L.-L; |JENG-YUH KO; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:39Z |
Potassium-titanyl-phosphate laser nasopharyngectomy with nasopharyngoscopic guidance for recurrent nasopharyngeal carcinoma.
|
Tan C.T; |Hsiao S.H; |Hwang J.H; |JENG-YUH KO; |Hsu M.M. |
